STAT3 and urinary bladder carcinoma: Its potential mechanism of inducing cisplatin resistance and apoptosis inhibition may be to activate STAT3 by binding to the octamer containing non POU (with highly conserved DNA binding domain) domain, and become a potential new target for bladder cancer treatment.